Redwood Wealth Management Group, LLC Precision Biosciences Inc Transaction History

Redwood Wealth Management Group, LLC

  • $205 Billion
  • Q4 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 25, 2024
BUY
$0.29 - $0.45 $4,553 - $7,065
15,700 Added 7.98%
212,490 $77.6 Million
Q3 2023

Oct 18, 2023
BUY
$0.34 - $0.69 $5,474 - $11,109
16,100 Added 8.91%
196,790 $67.2 Million
Q2 2023

Jul 20, 2023
SELL
$0.52 - $0.91 $715 - $1,251
-1,375 Reduced 0.76%
180,690 $95 Million
Q1 2023

Apr 19, 2023
BUY
$0.7 - $1.41 $5,131 - $10,335
7,330 Added 4.19%
182,065 $137 Million
Q4 2022

Feb 01, 2023
BUY
$0.97 - $45.0 $169,492 - $7.86 Million
174,735 New
174,735 $208 Million

Others Institutions Holding DTIL

# of Institutions
7
Shares Held
2.56M
Call Options Held
0
Put Options Held
0
View Full List

About PRECISION BIOSCIENCES INC

DTIL Quotes by TradingView
  • Ticker DTIL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 110,818,000
  • Market Cap $584M
  • Description
  • Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...
More about DTIL
Track This Portfolio

Track Redwood Wealth Management Group, LLC Portfolio

Follow Redwood Wealth Management Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redwood Wealth Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redwood Wealth Management Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email